Inactive Instrument
InspireMD Inc Stock NYSE
Stocks
US45779A5074
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 32.86M 28.8M 26.62M 24.49M 46.2M 3.17B 46.94M 318M 125M 1.55B 123M 121M 5.34B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 32.86M 28.8M 26.62M 24.49M 46.2M 3.17B 46.94M 318M 125M 1.55B 123M 121M 5.34B | EV / Sales 2026 * |
3.17x | EV / Sales 2027 * | 1.5x |
| Free-Float |
80.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: InspireMD Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 62 | 2019-12-31 |
Michael Lawless
DFI | Director of Finance/CFO | 58 | 2025-06-24 |
Shany Barel
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Stuka
CHM | Chairman | 71 | 2017-06-01 |
Michael Berman
BRD | Director/Board Member | 68 | 2013-02-06 |
Marvin Slosman
BRD | Director/Board Member | 62 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.31% | -3.21% | -17.17% | +8.37% | 123B | |
| -1.13% | -1.43% | +0.84% | -5.09% | 13.03B | |
| +0.11% | +2.93% | +62.51% | +106.54% | 9.21B | |
| +1.67% | +14.29% | -42.45% | -67.47% | 4.47B | |
| +0.98% | +0.85% | +6.39% | +47.04% | 2.7B | |
| +0.80% | -6.61% | -22.01% | -30.66% | 1.62B | |
| +3.55% | +3.10% | -9.81% | -18.90% | 1.6B | |
| +0.33% | +3.43% | +3.23% | -58.55% | 1.56B | |
| Average | +0.88% | +2.40% | -2.31% | -2.34% | 19.6B | |
| Weighted average by Cap. | +0.31% | -1.62% | -11.08% | +10.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.38M 9.09M 8.41M 7.73M 14.59M 1B 14.82M 101M 39.4M 490M 38.96M 38.11M 1.69B | 21.92M 19.21M 17.76M 16.33M 30.81M 2.11B 31.31M 212M 83.23M 1.03B 82.29M 80.5M 3.56B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
